AgomAb (Company)
Agonistic monoclonal antibody molecules
2
Funding Rounds
$97.6m
Money raised
Funding series
Funding Series Analysis
The company AgomAb (Company) has raised a total of $74m in funding over 2 rounds.
Key Insights:
- AgomAb Series B round, March 2021: $74m
- AgomAb funding round, April 2019: $23.6m
AgomAb Series B round, March 2021
$74m
AgomAb funding round, April 2019
$23.6m
Industries
AgomAb (Company) is active in the following industries: